Last reviewed · How we verify
NCT03165357
Sodium Bicarbonate Supplementation in Athletes
Phase 3 trial testing Sodium bicarbonate supplementation in Supplementation in 26 participants. Completed in 5 April 2016.
10 March 2016
Quick facts
| Lead sponsor | Poznan University of Life Sciences |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 10 October 2015 |
| Primary completion | 10 March 2016 |
| Estimated completion | 5 April 2016 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Sodium bicarbonate supplementation
- Placebo treatment
Conditions studied
- Supplementation — all drugs for Supplementation →
- Sport — all drugs for Sport →
Sponsor
Poznan University of Life Sciences
Who can join
Adults 20 to 43, any sex, with Supplementation or Sport. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study was to verify the effect of 10-day sodium bicarbonate (NaHCO3) and placebo (PLA) supplementation on body composition, physical capacity, as well as concentrations of the selected biochemical blood markers in trained athletes, in a randomised, double-blind, placebo-controlled crossover trial.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of chronic progressive-dose sodium bicarbonate ingestion on CrossFit-like performance: A double-blind, randomized cross-over trial.
Durkalec-Michalski K, Zawieja EE, Podgórski T, Łoniewski I, et al · · 2018 · cited 39× · PMID 29771966 · DOI 10.1371/journal.pone.0197480
Verify or expand the search:
- PubMed search for NCT03165357
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sodium bicarbonate supplementation
Trials testing the same drug.
- NCT03810404 — Acute Sodium Bicarbonate Supplementation in Athletes · Phase 3 · active not recruiting
- NCT03406065 — Sodium Bicarbonate Supplementation in Combat Sports Athletes · Phase 2, PHASE3 · completed
Other recruiting trials for Supplementation
Currently open trials in the same condition.
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07252778 — Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes · Phase 2, PHASE3 · recruiting
- NCT07213063 — Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Musc · NA · recruiting
- NCT05878106 — Creatine Supplementation and Resistance Training in Patients With Breast Cancer · NA · recruiting
- NCT05516212 — Caffeine Kinetics and CrossFit®-Specific Performance · Phase 2, PHASE3 · recruiting
Other Poznan University of Life Sciences trials
Trials by the same sponsor.
- NCT07245979 — Supplementation With Sirtuin Activators in Women With Increased Body Weight · NA · recruiting
- NCT06677411 — Vitamin D Status Fluctuations Over One Academic Year in Students · active not recruiting
- NCT06344377 — Betaine Supplementation and Lipid Metabolism in Overweight and Obese Pre-menopausal Women · NA · completed
- NCT06239363 — Dietary Salicylates and Preeclampsia · recruiting
- NCT06860581 — The Impact of Selected Probiotic Bacteria on Gut Microbiota, Stress Indicators and Nutritional Status of Young Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03165357 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Poznan University of Life Sciences
- Last refreshed: 24 May 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03165357.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing